---
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/237921406.md"
description: "The Nasdaq Biotechnology Index rose by 1.29%. Among the constituent stocks, CG Oncology increased by 24.99%, UroGen Pharma rose by 14.08%, and ADMA Biologics climbed by 12.03%. In contrast, Neurogene fell by 5.91%, Amylyx Pharmaceuticals dropped by 6.53%, and Q32 Bio decreased by 9.89%"
datetime: "2025-04-28T20:42:59.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/237921406.md)
  - [en](https://longbridge.com/en/news/237921406.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/237921406.md)
generator: "portal-rs"
---

# 

The Nasdaq Biotechnology Index closed up 1.29%.  
 Component stock CG Oncology rose 24.99%, UroGen Pharma increased by 14.08%, and ADMA Biologics was up 12.03%, ranking third.  
 Neurogene fell 5.91%, ranking third from the bottom, Amylyx Pharmaceuticals dropped 6.53%, and Q32 Bio decreased by 9.89%

### Related Stocks

- [CGON.US](https://longbridge.com/en/quote/CGON.US.md)
- [ADMA.US](https://longbridge.com/en/quote/ADMA.US.md)
- [URGN.US](https://longbridge.com/en/quote/URGN.US.md)
- [NGNE.US](https://longbridge.com/en/quote/NGNE.US.md)
- [QTTB.US](https://longbridge.com/en/quote/QTTB.US.md)
- [AMLX.US](https://longbridge.com/en/quote/AMLX.US.md)

## Related News & Research

- [Hi3D V1.0 wird Open Source: Das erste produktionserprobte Open-Source-KI-3D-Modell](https://longbridge.com/en/news/302966393.md)
- [Arcium: Distracted launches single-player poker on Solana - 24 Oct 2026](https://longbridge.com/en/news/302966124.md)
- [Chinese EVs found back door into Western car markets – at 40% off MSRP](https://longbridge.com/en/news/302966004.md)
- [China urges US to halt proposed expansion of outbound investment curbs](https://longbridge.com/en/news/302965472.md)
- [Crypto Strategist Who Nailed 2025 Bitcoin Top Warns BTC Could Drop Below $70,000 – Here’s His Price Target](https://longbridge.com/en/news/302980144.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**